
Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains
Author(s) -
Timothy J. Stuhlmiller,
Samantha M. Miller,
Jon S. Zawistowski,
Kazuhiro Nakamura,
Adriana S. Beltrán,
James S. Duncan,
Steven P. Angus,
Kyla Collins,
Deborah A. Granger,
Rachel A. Reuther,
Lee M. Graves,
Shawn M. Gomez,
Pei Fen Kuan,
Joel S. Parker,
Xin Chen,
Noah Sciaky,
Lisa A. Carey,
H. Shelton Earp,
Jian Jin,
Gary L. Johnson
Publication year - 2015
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/vnt3-7a98
Subject(s) - lapatinib , kinome , bromodomain , reprogramming , breast cancer , cancer research , medicine , biology , computational biology , kinase , cancer , genetics , trastuzumab , gene , epigenetics